Drugs / AXR-270
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04469998 | Jun → Dec 2020 | blepharitis | AxeroVision, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AXR-270 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04469998 ↗ |
| Route | Topical | “AXR-270 Topical Eyelid Cream” NCT04469998 ↗ |